These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33226022)

  • 1. High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds using HiBiT CRISPR Cell Lines.
    Riching KM; Mahan SD; Urh M; Daniels DL
    J Vis Exp; 2020 Nov; (165):. PubMed ID: 33226022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action.
    Riching KM; Mahan S; Corona CR; McDougall M; Vasta JD; Robers MB; Urh M; Daniels DL
    ACS Chem Biol; 2018 Sep; 13(9):2758-2770. PubMed ID: 30137962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Protein Degradation Phenotypic Studies Using HaloTag CRISPR/Cas9 Endogenous Tagging Coupled with HaloPROTAC3.
    Caine EA; Mahan SD; Johnson RL; Nieman AN; Lam N; Warren CR; Riching KM; Urh M; Daniels DL
    Curr Protoc Pharmacol; 2020 Dec; 91(1):e81. PubMed ID: 33332748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK Family PROTAC Profiling Reveals Distinct Kinetic Responses and Cell Cycle-Dependent Degradation of CDK2.
    Riching KM; Schwinn MK; Vasta JD; Robers MB; Machleidt T; Urh M; Daniels DL
    SLAS Discov; 2021 Apr; 26(4):560-569. PubMed ID: 33190579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring and deciphering protein degradation pathways inside cells.
    Daniels DL; Riching KM; Urh M
    Drug Discov Today Technol; 2019 Apr; 31():61-68. PubMed ID: 31200861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation.
    Riching KM; Caine EA; Urh M; Daniels DL
    Chem Soc Rev; 2022 Jul; 51(14):6210-6221. PubMed ID: 35792307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luciferase- and HaloTag-based reporter assays to measure small-molecule-induced degradation pathway in living cells.
    Schwalm MP; Saxena K; Müller S; Knapp S
    Nat Protoc; 2024 Aug; 19(8):2317-2357. PubMed ID: 38637703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR-Cas9 library.
    Wu Y; Kang T
    Chin J Cancer; 2016 Jun; 35(1):60. PubMed ID: 27357860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Simple and Scalable Strategy for Analysis of Endogenous Protein Dynamics.
    Schwinn MK; Steffen LS; Zimmerman K; Wood KV; Machleidt T
    Sci Rep; 2020 Jun; 10(1):8953. PubMed ID: 32488146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide CRISPR Analysis Identifies Substrate-Specific Conjugation Modules in ER-Associated Degradation.
    Leto DE; Morgens DW; Zhang L; Walczak CP; Elias JE; Bassik MC; Kopito RR
    Mol Cell; 2019 Jan; 73(2):377-389.e11. PubMed ID: 30581143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pick a Tag and Explore the Functions of Your Pet Protein.
    Vandemoortele G; Eyckerman S; Gevaert K
    Trends Biotechnol; 2019 Oct; 37(10):1078-1090. PubMed ID: 31036349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
    Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
    J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
    Ward CC; Kleinman JI; Brittain SM; Lee PS; Chung CYS; Kim K; Petri Y; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Nomura DK
    ACS Chem Biol; 2019 Nov; 14(11):2430-2440. PubMed ID: 31059647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysineless HiBiT and NanoLuc Tagging Systems as Alternative Tools Monitoring Targeted Protein Degradation.
    Lin H; Riching K; Lai MP; Lu D; Cheng R; Qi X; Wang J
    bioRxiv; 2024 May; ():. PubMed ID: 38798562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Small-Molecule Inhibitors Targeting the E3 Ubiquitin Ligase Activity of the Herpes Simplex Virus 1 ICP0 Protein Using an
    Deschamps T; Waisner H; Dogrammatzis C; Roy A; Chacko S; Perera C; Prisinzano TE; Kalamvoki M
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9 knockout screening for functional genomics.
    Shen Z; Ou G
    Sci China Life Sci; 2014 Jul; 57(7):733-4. PubMed ID: 25005538
    [No Abstract]   [Full Text] [Related]  

  • 18. Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs.
    Girardini M; Maniaci C; Hughes SJ; Testa A; Ciulli A
    Bioorg Med Chem; 2019 Jun; 27(12):2466-2479. PubMed ID: 30826187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-mediated knock-in of an optimized TetO repeat for live cell imaging of endogenous loci.
    Tasan I; Sustackova G; Zhang L; Kim J; Sivaguru M; HamediRad M; Wang Y; Genova J; Ma J; Belmont AS; Zhao H
    Nucleic Acids Res; 2018 Sep; 46(17):e100. PubMed ID: 29912475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins.
    Gama-Brambila RA; Chen J; Dabiri Y; Tascher G; Němec V; Münch C; Song G; Knapp S; Cheng X
    JACS Au; 2021 Jun; 1(6):777-785. PubMed ID: 34467332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.